TUG1 and liver cancer: In the present study, we show that upregulation of miR-132 inhibits the proliferation of liver cancer cells, and we identified TUG1 as a ceRNA that interferes with the binding of miR-132 to Shh, affecting the Hh pathway and the progression of HCC.